BCRX Biocryst Pharmaceuticals Inc.

$BCRX Wait...so that drop to $8 was just a rug pull to steal people's money and Orla is not going to crash and burn after all?

$BCRX Rather than worrying about competitor drugs, think about the impact once Navenibart is approved. 1. ~90%+ attack reduction 2. Strong Q6M efficacy 3. Clean safety/tolerability 4. Low injection-site reactions 5. Good patient preference/adherence 6. Ability to compete against Takhzyro and newer HAE prophylaxis products. navenibart itself could become a $1B+ peak annual product globally.

$BCRX Good news when Charlie was asked about the PHVS data today and how it possibly changes the sales outlook for Orladeyo. He answered with “we actually had them reporting better efficacy in our model projections”. So really a nothing burger for Charlie and team.

$BCRX I would only take a BO at around $30 a share. Otherwise , I’m waiting. Company also expects $2.0 billon in sales by 2030. My goal is to pivot in life at 2032. This will help me achieve my goal. Let’s go!!!

$BCRX After 20% haircut on top of being well undervalued, time for the buyback they have been hinting about. Let’s say 200m 😎

$BCRX At times I do have to wonder, am I the idiot for continuing to believe in this company when its pretty clear no one in the market does? To be continued....

$BCRX Still absolutely ridiculous this is back down to $8 a share and a 2B MC. Again. A growing, profitable company that trades for less than some bios that dont even have any revenue. I'm sure there are plenty of stocks out there where SH feel that their company is the most hated on the market, but this could surely give any of them a run for their money.

$BCRX Bought 5000 at 7.98 - probably my last buy for a while here. That $7 is just too appetizing.

$BCRX blocked that idiot fergus. 2 years overdue. nobody has ever contributed less per word on any topic, anywhere, ever.

$BCRX the sell off should be over. You guys should have a clear run now. Price should move high and pretty quickly

$BCRX i believe navenibart is going to be great and with orladeyo hits $1.8 billion in sales

$BCRX The most exciting thing that’s happened to this stock in the last year was a bullshit buyout rumor. Atrocious.

$BCRX at this point they could announce Orladeyo cures baldness, prints money, and comes with free electricity and the stock would probably open down 8%. Unserious price action for weeks.

$BCRX Remember when Stonehouse was so cocky about 9930 that he pulled the offering? The stock dropped from $17 to $15 in after hours when the offering was announced and he was insulted. Pulling that offering has been the kiss of death since that day about 5 years ago. He really pissed the big money institutions off! Charlie can right the ship, but only if he goes on the offensive by announcing a stock buyback plan, making it a point to put shareholders first, and of course having a successful Navenibart readout. Those are the things that will determine whether this gets back to ATH someday or is cut in half from here. It’s truly a gamble for us guys!!!

$BCRX added 4300 shares this week. Some $10 put assignments at 9.05 cost basis, and buys at $8.25. Nearly got all my shares back that I sold at 10.56. I thought I was getting out! But looks like I’m getting sucked back in.

$BCRX Charlie said “kid demand exceeding their expectations this far”. Means we probably are headed to $7.50 😂

$BCRX the kids pellets are the difference maker, thus allow this to hit a billion in sales. Works as a kid, why the hell would you ever switch? It’s been said buy $PHVS has a long way to go before I’m scared

$BCRX I don't have kids, but I immagine owing this stock is very similar to the daily disappointment a parent with a loser kid must feel.

$BCRX Historically, this has to be one of the worst performing stocks in NASDAQ history. A true POS. Another example of goid drugs not equating to good drug companies.

$BCRX an accountant at Bio posted this on LinkedIn Sadly, due to organizational restructuring, my role at BioCryst Pharmaceuticals was eliminated and yesterday was my last day. While getting that news is never easy, I am grateful for the opportunity to have worked there. I enjoyed my team... more